Fulgent Genetics, Inc. FLGT
Fulgent Genetics, Inc. statistics & valuation
Market cap$566.9M
P / S1.8×
P / B0.5×
Net margin-18.8%
Return on equity-5.4%
FCF margin-38.5%
Return on capital-8.1%
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 40.6% | 37.8% | 36.1% | 59.3% | 78.3% | 78.7% | 56.6% | 49.9% | 54.3% | 63.2% |
| Operating margin | -28.2% | -26.1% | -67.6% | 28.8% | 68.1% | 68.8% | -1.3% | -23.7% | -18.6% | 5.0% |
| Net margin | -18.8% | -15.1% | -58.0% | 23.2% | 51.1% | 50.8% | -1.3% | -26.3% | -13.4% | -29.3% |
| FCF margin | -38.5% | -6.8% | 1.7% | 37.9% | 51.9% | 25.0% | 13.3% | -14.0% | -8.4% | 3.5% |
| Return on assets | -5.0% | -3.5% | -13.6% | 10.3% | 39.7% | 30.6% | -0.5% | -10.4% | -4.4% | -9.2% |
| Return on equity | -5.4% | -3.8% | -14.8% | 11.3% | 43.5% | 37.6% | -0.5% | -11.0% | -4.6% | -9.8% |
| Current ratio | 6.48 | 4.85 | 6.96 | 7.13 | 5.81 | 4.02 | 9.96 | 14.44 | 10.98 | 7.88 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.